Hepatitis C virus infection in patients with tuberculosis in Central Brazil

Int J Tuberc Lung Dis. 2011 Oct;15(10):1397-402. doi: 10.5588/ijtld.10.0636.

Abstract

Setting: Goiânia City, Goiás State, Brazil.

Objectives: To determine the prevalence of hepatitis C virus (HCV) infection, risk factors, HCV genotype/ subtype, HCV viral load and human immunodeficiency virus (HIV) status in patients with tuberculosis (TB) in Central Brazil.

Design: A cross-sectional study was carried out with 402 patients who were under tuberculosis (TB) treatment in the reference hospital for infectious diseases in Goiânia, Goiás, Central Brazil.

Results: The prevalence rates of HCV and HIV were respectively 7.5% and 27.6%. Two thirds of the HCV-infected patients (20/30) were HIV-positive. Age, injecting drug use (IDU) and HIV status were factors independently associated with HCV infection. HCV RNA was detected in 23 serum samples; HCV RNA levels were measured in 22/23 samples. HCV RNA level was slightly higher in HCV-HIV co-infected patients than in HCV monoinfected patients. Genotypes 1 (n = 17) and 3 (n = 6) were determined by LiPA. Using phylogenetic tree analysis of the NS5B region, subtypes 1a (n = 12), 1b (n = 2) and 3a (n = 6) were identified.

Conclusion: These data indicate that patients with TB may benefit from integrated HIV and HCV screening, which may have an important impact upon TB management and treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Brazil
  • Child
  • Child, Preschool
  • Coinfection*
  • Cross-Sectional Studies
  • Female
  • Genotype
  • HIV Infections / diagnosis
  • HIV Infections / epidemiology
  • HIV Infections / virology
  • HIV Seropositivity
  • HIV-1 / immunology
  • Hepacivirus / genetics
  • Hepacivirus / immunology
  • Hepatitis C / diagnosis
  • Hepatitis C / epidemiology*
  • Hepatitis C Antibodies / blood
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • RNA, Viral / analysis
  • Risk Assessment
  • Risk Factors
  • Tuberculosis / diagnosis
  • Tuberculosis / epidemiology*
  • Tuberculosis / therapy
  • Young Adult

Substances

  • Hepatitis C Antibodies
  • RNA, Viral